Literature DB >> 16880480

Sub-syndromal and syndromal symptoms in the longitudinal course of bipolar disorder.

Eugene S Paykel1, Rosemary Abbott, Richard Morriss, Hazel Hayhurst, Jan Scott.   

Abstract

BACKGROUND: There have been few detailed longitudinal symptom studies of bipolar disorder. AIMS: To describe the course of bipolar disorder over 18 months in 204 patients receiving mental healthcare.
METHOD: Patients were interviewed every 8 weeks, with weekly ratings of depression, mania and overall severity.
RESULTS: Participants were symptomatic 53% of the time, with sub-syndromal symptoms present for twice as long as major disorder, and depressive symptoms three times more than manic symptoms. Individuals who were experiencing an episode at baseline spent 33% of the 18 months with substantial sub-syndromal symptoms, 17% with major disorder and 28% symptom free. Those not experiencing a baseline episode spent twice as long symptom free and half as long at disorder levels. Changes in symptom level were frequent. Predictors of sub-syndromal symptoms were similar to those of major disorder.
CONCLUSIONS: Sub-syndromal residual symptoms are an important problem in recurrent bipolar disorder and require therapeutic intervention.

Entities:  

Mesh:

Year:  2006        PMID: 16880480     DOI: 10.1192/bjp.bp.105.013870

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  33 in total

1.  Managing bipolar disorder from urgent situations to maintenance therapy.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

2.  A web-based, peer-supported self-management intervention to reduce distress in relatives of people with psychosis or bipolar disorder: the REACT RCT.

Authors:  Fiona Lobban; Nadia Akers; Duncan Appelbe; Rossella Iraci Capuccinello; Lesley Chapman; Lizzi Collinge; Susanna Dodd; Sue Flowers; Bruce Hollingsworth; Mahsa Honary; Sonia Johnson; Steven H Jones; Ceu Mateus; Barbara Mezes; Elizabeth Murray; Katerina Panagaki; Naomi Rainford; Heather Robinson; Anna Rosala-Hallas; William Sellwood; Andrew Walker; Paula R Williamson
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

Review 3.  Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments.

Authors:  Michael W Jann
Journal:  Am Health Drug Benefits       Date:  2014-12

4.  Cyclothymic disorder in youth: why is it overlooked, what do we know and where is the field headed?

Authors:  Anna R Van Meter; Eric A Youngstrom
Journal:  Neuropsychiatry (London)       Date:  2012-12-01

5.  Patient-Important Outcomes in the Long-Term Treatment of Bipolar Disorder: A Mixed-Methods Approach Investigating Relative Preferences and a Proposed Taxonomy.

Authors:  Øystein Eiring; Magne Nylenna; Kari Nytrøen
Journal:  Patient       Date:  2016-04       Impact factor: 3.883

Review 6.  Partial remission, residual symptoms, and relapse in depression.

Authors:  E S Paykel
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

7.  The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder.

Authors:  Ellen Frank; Isabella Soreca; Holly A Swartz; Andrea M Fagiolini; Alan G Mallinger; Michael E Thase; Victoria J Grochocinski; Patricia R Houck; David J Kupfer
Journal:  Am J Psychiatry       Date:  2008-10-01       Impact factor: 18.112

Review 8.  The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?

Authors:  Isabella Soreca; Ellen Frank; David J Kupfer
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

9.  The role of lamotrigine in the management of bipolar disorder.

Authors:  Felicity Ng; Karen Hallam; Nellie Lucas; Michael Berk
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

10.  Cognitive processing in bipolar disorder conceptualized using the Interactive Cognitive Subsystems (ICS) model.

Authors:  C L Lomax; P J Barnard; D Lam
Journal:  Psychol Med       Date:  2008-09-16       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.